ArticleDiabetes, obesity & metabolism2026

Cardiorenal Mortality and Safety Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m

Shao-Chia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.